The clinical need for new radiopharmaceuticals and new targets has changed in recent years. More than 10 years ago, Schwaiger and Wester [1] emphasized the importance of the combination of new specific radiopharmaceuticals and ‘tar- geted therapy’ for the realization of personalized medicine.
Boschi, S., Todde, S. (2023). Radiopharmaceutical need between the clinic and regulatory agencies: how philosophy could explain 'the road taken'. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 50, 2921-2924 [10.1007/s00259-023-06244-x].
Radiopharmaceutical need between the clinic and regulatory agencies: how philosophy could explain 'the road taken'
Boschi, Stefano;
2023
Abstract
The clinical need for new radiopharmaceuticals and new targets has changed in recent years. More than 10 years ago, Schwaiger and Wester [1] emphasized the importance of the combination of new specific radiopharmaceuticals and ‘tar- geted therapy’ for the realization of personalized medicine.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
